Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab.
Pawsey A, Mahalingam P, Senthivel N, Ramessur A, Turnbull E, Usman S, Browne R, Patel A, Stewart A, Tookman L, Counsell N, Miller R, Nicum S, Eminowicz G. Pawsey A, et al. Among authors: senthivel n. Clin Oncol (R Coll Radiol). 2024 Oct 11;37:103656. doi: 10.1016/j.clon.2024.10.008. Online ahead of print. Clin Oncol (R Coll Radiol). 2024. PMID: 39504640
A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodules.
Hunter B, Chen M, Ratnakumar P, Alemu E, Logan A, Linton-Reid K, Tong D, Senthivel N, Bhamani A, Bloch S, Kemp SV, Boddy L, Jain S, Gareeboo S, Rawal B, Doran S, Navani N, Nair A, Bunce C, Kaye S, Blackledge M, Aboagye EO, Devaraj A, Lee RW. Hunter B, et al. Among authors: senthivel n. EBioMedicine. 2022 Dec;86:104344. doi: 10.1016/j.ebiom.2022.104344. Epub 2022 Nov 10. EBioMedicine. 2022. PMID: 36370635 Free PMC article.
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer.
Battisti NML, Andres MS, Lee KA, Ramalingam S, Nash T, Mappouridou S, Senthivel N, Asavisanu K, Obeid M, Tripodaki ES, Angelis V, Fleming E, Goode EF, John S, Rosen SD, Allen M, Stanway S, Lyon AR, Ring A. Battisti NML, et al. Among authors: senthivel n. Breast Cancer Res Treat. 2021 Jul;188(1):149-163. doi: 10.1007/s10549-021-06192-w. Epub 2021 Apr 5. Breast Cancer Res Treat. 2021. PMID: 33818652